Transfer PriceTransfer Pricing Litigation JAN 16, 2012 Back to NewsMDW commented on the Supreme Court of Canada hearing between GlaxoSmithKline Inc. v. The Queen regarding the arm’s length price for the active ingredient of a blockbuster drug and whether, or not, it should include the related intangibles.Request More information: Your Name (required) Your Email (required) Your Message Share:
